Hematopoietic growth factors: Current knowledge, future prospects
Tóm tắt
Từ khóa
Tài liệu tham khảo
Tavassoli, 1980, Bone marrow: The seedbed of blood, 57
Reissmann, 1950, Studies on the mechanisms of erythropoietic stimulation in parabiotic rats during hypoxia, Blood, 5, 372, 10.1182/blood.V5.4.372.372
Stohlman, 1954, Evidence for a humoral regulation of erythropoiesis: Studies on a patient with polycythemia secondary to regional hypoxia, Blood, 9, 721, 10.1182/blood.V9.7.721.721
Jacobson, 1957, Studies on erythropoiesis, VII. The role of the kidney in the production of erythropoietin, Trans Assoc Am Physicians, 70, 305
Goldwasser, 1971, Purification of erythropoietin, Proc Natl Acad Sci USA, 68, 697, 10.1073/pnas.68.4.697
Miyake, 1977, Purification of human erythropoietin, J Biol Chem, 252, 5558, 10.1016/S0021-9258(19)63387-9
Lin, 1985, Cloning and expression of the human erythropoietin gene, Proc Natl Acad Sci USA, 82, 7580, 10.1073/pnas.82.22.7580
Jacobs, 1985, Isolation and characterization of genomic and cDNA clones of human erythropoietin, Nature, 313, 806, 10.1038/313806a0
Till, 1961, Direct measurement of the radiation sensitivity of normal mouse bone marrow cells, Radiat Res, 14, 213, 10.2307/3570892
Pluznik, 1965, The cloning of normal “mast” cells in tissue culture, J Cell Physiol, 66, 319, 10.1002/jcp.1030660309
Bradley, 1966, The growth of mouse bone marrow cells in vitro, Aust J Exp Biol Med Sci, 44, 287, 10.1038/icb.1966.28
Moore, 1991, Clinical implications of positive and negative hematopoietic stem cell regulators, Blood, 78, 1, 10.1182/blood.V78.1.1.1
Spangrude, 1988, Purification and characterization of mouse hematopoietic stem cells, Science, 241, 58, 10.1126/science.2898810
Brandt, 1988, Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro, J Clin Invest, 82, 1017, 10.1172/JCI113658
Brandt, 1990, Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow, J Clin Invest, 86, 932, 10.1172/JCI114795
Andrews, 1990, Human hematopoietic precursors in long-term culture: Single CD34_+cells that lack detectable T cell, B cell, and myeloid cell antigens produce multiple colony-forming cells when cultured with marrow stromal cells, J Exp Med, 172, 335, 10.1084/jem.172.1.355
Verfaillie, 1990, Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma, J Exp Med, 172, 509, 10.1084/jem.172.2.509
Paul, 1990, Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine, Proc Natl Acad Sci USA, 87, 7512, 10.1073/pnas.87.19.7512
Bussolino, 1989, Granulocyte—and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate, Nature, 337, 471, 10.1038/337471a0
Bussolino, 1991, In vitro and in vivo activation of endothelial cells by colony-stimulating factors, J Clin Invest, 87, 986, 10.1172/JCI115107
Dedhar, 1988, Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin, Proc Natl Acad Sci USA, 85, 9253, 10.1073/pnas.85.23.9253
Berdel, 1989, Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells, Blood, 73, 80, 10.1182/blood.V73.1.80.80
Baldwin, 1989, Nonhematopoietic tumor cells express functional GM-CSF receptors, Blood, 73, 1033, 10.1182/blood.V73.4.1033.1033
Avalos, 1990, Human granulocyte colony-stimulat- ing factor: Biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines, Blood, 75, 851, 10.1182/blood.V75.4.851.851
McDonald, 1987, High doses of recombinant erythropoietin stimulate platelet production in mice, Exp Hematol, 15, 719
Berridge, 1988, Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat, Blood, 72, 970, 10.1182/blood.V72.3.970.bloodjournal723970
Ishibashi, 1987, Human recombinant erythropoietin promotes differentiation of murine megakaryocytes in vitro, J Clin Invest, 79, 286, 10.1172/JCI112796
Ikebuchi, 1988, Synergistic factors for stem cell proliferation: Further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor, Blood, 72, 2007, 10.1182/blood.V72.6.2007.2007
Ikebuchi, 1988, Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors, Proc Natl Acad Sci USA, 85, 3445, 10.1073/pnas.85.10.3445
Carnot, 1906, Sur l'activité hemopoietique des differents organeau au cours de la regeneration du sang, CR Seances Acad Sci, 143, 432
Goldberg, 1988, Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein, Science, 242, 1412, 10.1126/science.2849206
Kickler, 1988, Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors, JAMA, 260, 65, 10.1001/jama.260.1.65
Miller, 1990, Decreased erytyropoietin response in patients with the anemia of cancer, N Engl J Med, 322, 1689, 10.1056/NEJM199006143222401
Faquin, 1990, Effects of inflammatory cytokines on erythropoietin production in Hep3B cells, Blood, 76, 142
Baer, 1987, Blunted erythropoietin response to anaemia in rheumatoid arthritis, Br J Haematol, 66, 559, 10.1111/j.1365-2141.1987.tb01344.x
Jelkman, 1990, Immunoreactive erythropoietin in the anemia of nonrenal chronic diseases, Biomed Biochim Acta, 49, S265
Spivak, 1989, Serum immunoreactive erythropoietin in HIV-infected patients, JAMA, 261, 3104, 10.1001/jama.261.21.3104
Winearls, 1986, Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic dialysis, Lancet, 2, 1175, 10.1016/S0140-6736(86)92192-6
Eschbach, 1987, Correction of the anemia of end-stage renal disease with recombinant human erythropoietin, N Engl J Med, 316, 73, 10.1056/NEJM198701083160203
Egrie, 1988, Pharmacokinetics of recombinant human erythropoietin (rHuEpo) administered to hemodialysis (HD) patients, Kidney Int, 33, 262
Lim, 1989, Recombinant human erythropoietin treatment in pre-dialysis patients, Ann Intern Med, 110, 108, 10.7326/0003-4819-110-2-108
McMahon, 1990, Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers, Blood, 76, 1718, 10.1182/blood.V76.9.1718.1718
Oster, 1990, Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration, J Clin Oncol, 8, 956, 10.1200/JCO.1990.8.6.956
Ludwig, 1990, Erythropoietin treatment of anemia associated with multiple myeloma, N Engl J Med, 322, 1693, 10.1056/NEJM199006143222402
Henry, 1990, Treatment of anemia in cancer patients on cisplatin chemotherapy with recombinant human erythropoietin, Proc Am Soc Clin Oncol, 9, 182
Fischl, 1990, Recombinant human erythropoietin for patients with AIDS treated with zidovudine, N Engl J Med, 322, 1488, 10.1056/NEJM199005243222103
Stein, 1991, Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes, Blood, 78, 1658, 10.1182/blood.V78.7.1658.1658
Burgess, 1980, Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemia cells, Int J Cancer, 26, 647, 10.1002/ijc.2910260517
Metcalf, 1980, Clonal extinction of myelomonocytic leukemia cells by serum from mice injected with endotoxin, In J Cancer, 25, 225
Nicola, 1983, Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells: Identification as granulocyte colony-stimulating factor, J Biol Chem, 258, 9017, 10.1016/S0021-9258(18)32158-6
Nicola, 1985, Identification of the human analogue of a regulator that induces differentiation in murine leukaemic cells, Nature, 314, 625, 10.1038/314625a0
Souza, 1986, Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells, Science, 232, 61, 10.1126/science.2420009
Demetri, 1991, Granulocyte colony-stimulating factor and its receptor, Blood, 78, 2791, 10.1182/blood.V78.11.2791.bloodjournal78112791
Hammond, 1991, Chronic neutropenia: A new canine model induced by human granulocyte colony-stimulating factor, J Clin Invest, 87, 704, 10.1172/JCI115049
Watari, 1989, Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay, Blood, 73, 117, 10.1182/blood.V73.1.117.117
Kawakami, 1990, Levels of serum granulocyte colony-stimulating factor in patients with infections, Blood, 76, 1962, 10.1182/blood.V76.10.1962.1962
Welte, 1985, Purification and biological characterization of human pluripotent hematopoietic colony-stimulating factor, Proc Natl Acad Sci USA, 82, 1526, 10.1073/pnas.82.5.1526
Platzer, 1985, Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells, J Exp Med, 162, 1788, 10.1084/jem.162.6.1788
Strife, 1987, Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells, Blood, 69, 1508, 10.1182/blood.V69.5.1508.1508
Ogawa, 1989, Humoral regulation of stem cell proliferation, Ann N Y Acad Sci, 554, 185, 10.1111/j.1749-6632.1989.tb22420.x
Bronchud, 1987, Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer, Br J Cancer, 56, 809, 10.1038/bjc.1987.295
Gabrilove, 1988, Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium, J Clin Invest, 82, 1454, 10.1172/JCI113751
Morstyn, 1988, Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy, Lancet, 1, 667, 10.1016/S0140-6736(88)91475-4
Gabrilove, 1988, Effect of granulocyte colonystimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium, N Engl J Med, 318, 1414, 10.1056/NEJM198806023182202
Morstyn, 1989, Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colonystimulating factor with optimization of dose and duration of therapy, J Clin Oncol, 7, 1554, 10.1200/JCO.1989.7.10.1554
Crawford, 1991, Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer, N Engl J Med, 325, 164, 10.1056/NEJM199107183250305
Bronchud, 1989, The use of granulocyte colonystimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer, Br J Cancer, 60, 121, 10.1038/bjc.1989.234
Demetri, 1991, Recombinant methionyl granulocyte-CSF (r-metG-CSF) allows an increase in the dose intensity of cyclophosphamide/doxorubicin/5-fluorouracil (CAF) in patients with advanced breast cancer, Proc Am Soc Clin Oncol, 10, 70
Sheridan, 1989, Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation, Lancet, 2, 891, 10.1016/S0140-6736(89)91552-3
Taylor, 1989, Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease, J Clin Oncol, 7, 1791, 10.1200/JCO.1989.7.12.1791
Nemunaitis, 1991, Recombinant granulocytemacrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer, N Engl J Med, 324, 1773, 10.1056/NEJM199106203242504
Vellenga, 1987, Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures, Leukemia, 1, 584
Vellenga, 1987, The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia, Blood, 69, 1771, 10.1182/blood.V69.6.1771.1771
Demetri, 1989, Hemopoietins and leukemia, 535
Negrin, 1989, Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: A phase I–II trial, Ann Intern Med, 110, 976, 10.7326/0003-4819-110-12-976
Negrin, 1990, Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor, Blood, 76, 36, 10.1182/blood.V76.1.36.36
Nagler, 1990, Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes, Leukemia, 4, 193
Nagler, 1990, Impact of marrow cytogenetics and morphology in in vitro hematopoiesis in the myelodysplastic syndromes: Comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF, Blood, 76, 1299, 10.1182/blood.V76.7.1299.1299
Ohno, 1990, Effect of granulocyte colonystimulating factor after intensive induction therapy in relapsed or refractory acute leukemia, N Engl J Med, 323, 871, 10.1056/NEJM199009273231304
Hammond, 1989, Treatment of cyclic neutropenia with granulocyte colony-stimulating factor, N Engl J Med, 320, 1306, 10.1056/NEJM198905183202003
Bonilla, 1989, Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocutosis, N Engl J Med, 320, 1574, 10.1056/NEJM198906153202402
Welte, 1990, Differential effects of granulocytemacrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia, Blood, 75, 1056, 10.1182/blood.V75.5.1056.1056
Jakubowski, 1989, Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia, N Engl J Med, 320, 38, 10.1056/NEJM198901053200107
Wodzinski, 1991, Differential effect of G-CSF and GM-CSF in acquired chronic neutropenia, Br J Haematol, 77, 249, 10.1111/j.1365-2141.1991.tb07987.x
Mitsuyasu, 1990, The use of myeloid hematopoietic growth factors in patients with HIV infection, Int J Cell Cloning, 1, 347, 10.1002/stem.5530080732
Miles, 1991, Combined therapy with recombinant granulocyte-colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine, Blood, 77, 2109, 10.1182/blood.V77.10.2109.2109
Stanley, 1977, Factors regulating macrophage production and growth: Purification and some properties of the colony stimulating factor from medium conditioned by mouse L-cells, J Biol Chem, 252, 4305, 10.1016/S0021-9258(17)40265-1
Broxmeyer, 1990, Enhanced stimulation of human bone marrow macrophage colony formation in vitro by recombinant human macrophage colony-stimulating factor in agarose medium and at low oxygen tension, Blood, 76, 323, 10.1182/blood.V76.2.323.323
Kawasaki, 1985, Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1), Science, 230, 291, 10.1126/science.2996129
Wong, 1987, Human CSF-1: Molecular cloning and expression of 4 kb cDNA encoding the human urinary protein, Science, 235, 1504, 10.1126/science.3493529
Rettenmier, 1989, The mononuclear phagocyte colony-stimulating factor, 479
Das, 1982, Structure-function studies of a colony-stimulating factor (CSF-1), J Biol Chem, 257, 13679, 10.1016/S0021-9258(18)33500-2
Sherr, 1990, Colony-stimulating factor-1 receptor, Blood, 75, 1, 10.1182/blood.V75.1.1.bloodjournal7511
Sherr, 1985, The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1, Cell, 41, 665, 10.1016/S0092-8674(85)80047-7
Das, 1981, Human colony-stimulating factor (CSF-1) radioimmunoassay: Resolution of three classes of human colony-stimulating factors, Blood, 58, 630, 10.1182/blood.V58.3.630.630
Bartocci, 1987, Macrophages specifically regulate the concentration of their own growth factor in the circulation, Proc Natl Acad Sci USA, 84, 6179, 10.1073/pnas.84.17.6179
Karbassi, 1987, Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: Evidence for augmented expression of mannose receptors, J Immunol, 139, 417, 10.4049/jimmunol.139.2.417
Munn, 1989, Antibody dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor: Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays, J Exp Med, 170, 511, 10.1084/jem.170.2.511
Munn, 1990, Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor, J Exp Med, 172, 231, 10.1084/jem.172.1.231
Ulich, 1990, In vivo hematologic effects of recombinant human macrophage colony-stimulating factor, Blood, 75, 846, 10.1182/blood.V75.4.846.846
Garnick, 1989, Clinical promise of M-CSF, IL-3, and IL-6, 495
Bajorin, 1990, Recombinant macrophage colony-stimulating factor (rhM-CSF): A phase I trial in patients (pts) with metastatic melanoma, Proc Am Soc Clin Oncol, 9, 183
Bajorin, 1991, Macrophage colony-stimulating factor: Biological effects and potential applications for cancer therapy, Semin Hematol, 28, 42
Budd, 1991, Phase I trial of subcutaneous (SQ) recombinant monocyte/macrophage-colony stimulating factor (rM-CSF) in patients with refractory malignancies, Blood, 78, 22
Nemunaitis, 1991, Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections, Blood, 78, 907, 10.1182/blood.V78.4.907.907
Gemlo, 1988, Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin-2 and lymphokine-activated killer cells, Cancer Res, 48, 5864
Mier, 1988, Induction of circulating tumor necrosis factor (TNF-a) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients, J Clin Immunol, 8, 426, 10.1007/BF00916947
Lee, 1989, Cardiorespiratory effects of immunotherapy with interleukin-2, J Clin Oncol, 7, 7, 10.1200/JCO.1989.7.1.7
Margolin, 1989, Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: Analysis of toxicity and management guidelines, J Clin Oncol, 7, 486, 10.1200/JCO.1989.7.4.486
Parkinson, 1988, Interleukin-2 in cancer therapy, Semin Oncol, 15, 10
Rosenberg, 1986, A new approach to the adoptive immunotherapy of cancer with tumor infiltrating lymphocytes, Science, 233, 1318, 10.1126/science.3489291
Sanderson, 1985, Identification of a lymphokine that stimulates eosinophil differentiation in vitro, J Exp Med, 162, 60, 10.1084/jem.162.1.60
Azuma, 1986, Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue, Nucleic Acids Res, 14, 9149, 10.1093/nar/14.22.9149
Campbell, 1987, Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin-5), Proc Natl Acad Sci USA, 84, 6629, 10.1073/pnas.84.19.6629
Yokota, 1987, Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating activities: Relationship to interleukin-5, Proc Natl Acad Sci USA, 84, 7388, 10.1073/pnas.84.21.7388
Harriman, 1988, The role of IL-5 in IgA B cell differentiation, J Immunol, 140, 3033, 10.4049/jimmunol.140.9.3033
Takatsu, 1987, Interleukin 5, a T-cell derived B-cell differentiation factor, also induces cytotoxic T lymphocytes, Proc Natl Acad Sci USA, 84, 4234, 10.1073/pnas.84.12.4234
Kinashi, 1986, Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II, Nature, 324, 70, 10.1038/324070a0
Yamaguchi, 1988, Highly purified murine interleukin-5 (IL-5) stimulated eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor, J Exp Med, 167, 1737, 10.1084/jem.167.5.1737
Samoszuk, 1990, Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia, Blood, 75, 13, 10.1182/blood.V75.1.13.13
Vellenga, 1991, The supportive effects of interleukin-7 on eosinophil progenitors from human bone marrow cells can be blocked by anti-Interleukin-5, Blood, 78, 48
Namen, 1988, B cell precursor growth-promoting activity. Verification and characterization of a growth factor active on lymphocyte precursors, J Exp Med, 167, 988, 10.1084/jem.167.3.988
Namen, 1988, Stimulation of B-cell progenitors by cloned murine interleukin 7, Nature, 333, 571, 10.1038/333571a0
Goodwin, 1989, Human interleukin 7: Molecular cloning and growth factor activity on human and murine B-lineage cells, Proc Natl Acad Sci USA, 86, 302, 10.1073/pnas.86.1.302
Wu, 1991, Antitumor effect of recombinant human interleukin-7 in combination with local hyperthermia in B16a melanoma bearing mice, Blood, 78, 18
Robertson, 1991, Effects of natural killer cell stimulatory factor (NKSF) on cytolytic activity and proliferation of human natural killer (NK) cells, Blood, 78, 1052
Gately, 1991, Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor), J Immunol, 147, 874, 10.4049/jimmunol.147.3.874
Burgess, 1977, Purification and properties of colony-stimulating factor from mouse lung conditioned medium, J Biol Chem, 252, 1998, 10.1016/S0021-9258(18)71855-3
Gasson, 1984, Purified human granulocyte-macrophage colony-stimulating factor: Direct action on neutrophils, Science, 226, 1339, 10.1126/science.6390681
Gough, 1984, Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor, Nature, 309, 763, 10.1038/309763a0
Gough, 1985, Structure and expression of mRNA for murine granulocyte-macrophage colony stimulating factor, EMBO J, 4, 645, 10.1002/j.1460-2075.1985.tb03678.x
Wong, 1985, Human GM-CSF: Molecular cloning of the complementary DNA and purification of the natural and recombinant proteins, Science, 228, 810, 10.1126/science.3923623
Yang, 1986, Human IL-3 (Multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3, Cell, 47, 3, 10.1016/0092-8674(86)90360-0
Miyajima, 1986, Expression of murine and human granulocyte-macrophage colony-stimulating factors in S. cerevisiae: Mutagenesis of the potential glycosylation sites, EMBO J, 5, 1193, 10.1002/j.1460-2075.1986.tb04346.x
Moonen, 1987, Increased biological activity of deglycosylated recombinant human granulocyte/macrophage colonystimulating factor produced by yeast or animal cells, Proc Natl Acad Sci USA, 84, 4428, 10.1073/pnas.84.13.4428
Burgess, 1987, Purification and properties of bacterially synthesized human granulocyte-macrophage colony-stimulating factor, Blood, 69, 43, 10.1182/blood.V69.1.43.43
Sieff, 1985, Human recombinant granulocyte-macrophage colony-stimulating factor: A multilineage hemopoietin, Science, 230, 1171, 10.1126/science.3877981
Kaushansky, 1986, Genomic cloning, characterization, and multilineage growth promoting activity of human granulocyte-macrophage colony-stimulating factor, Proc Natl Acad Sci USA, 83, 3101, 10.1073/pnas.83.10.3101
Metcalf, 1986, Biological properties in vitro of a recombinant granulocyte-macrophage colony-stimulating factor, Blood, 67, 37, 10.1182/blood.V67.1.37.37
Tomonaga, 1986, Biosynthetic (recombinant) human granulocyte-macrophage colony-stimulating factor: Effect on normal bone marrow and leukemia cell lines, Blood, 67, 31, 10.1182/blood.V67.1.31.31
Metcalf, 1980, Direct stimulation by purified GM-CSF of the proliferation of multipotential and erythroid precursor cells, Blood, 55, 138, 10.1182/blood.V55.1.138.138
Cebon, 1988, Pharmacokinetics of human granulocytemacrophage colony-stimulating factor using a sensitive immunoassay, Blood, 72, 1340, 10.1182/blood.V72.4.1340.1340
Donahue, 1986, Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF, Nature, 321, 872, 10.1038/321872a0
Groopman, 1987, Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome, N Engl J Med, 317, 593, 10.1056/NEJM198709033171003
Antman, 1988, Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression, N Engl J Med, 319, 593, 10.1056/NEJM198809083191001
Lieschke, 1989, Characterization of the clinical effects of the first dose of granulocyte-macrophage colony-stimulating factor, Blood, 74, 2634, 10.1182/blood.V74.8.2634.2634
Devereux, 1987, Transient leukopenia induced by granulocyte-macrophage colony-stimulating factor, Lancet, 2, 1523, 10.1016/S0140-6736(87)92654-7
Demetri, 1992, GM-CSF: Preclinical and clinical investigations, Semin Oncol
Brandt, 1988, Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstituion after high-dose chemotherapy and autologous bone marrow transplantation, N Engl J Med, 318, 869, 10.1056/NEJM198804073181401
Link, 1989, Treatment with recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation, Bone Marrow Transplant, 4S, 79
Linkesch, 1990, Rhu-GM-CSF after ultrahigh dose carboplatin, VP-16, cyclophosphamide with ABMT in refractory germ cell cancer, Proc Am Soc Clin Oncol, 9, 141
Lazarus, 1990, Phase II ECOG trial of recombinant granulocyte-macrophage colony stimulating factor (rhGM-CSF) after autologous bone marrow transplant (AuBMT) for relapsed non-Hodgkin's lymphoma (NHL), Proc Am Soc Clin Oncol, 9, 15
Devereux, 1989, GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease, Bone Marrow Transplant, 4, 49
Blazar, 1989, In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts, Blood, 73, 849, 10.1182/blood.V73.3.849.849
Vadhan-Raj, 1987, Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes, N Engl J Med, 317, 1545, 10.1056/NEJM198712173172501
Schuster, 1990, Randomized trial of subcutaneous granulocyte-macrophage colony-stimulating factor (GM-CSF) versus observation in patients (PTS) with myelodysplastic syndrome (MDS) or aplastic anemia (AA), Proc Am Soc Clin Oncol, 9, 205
Antin, 1988, Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome, Blood, 72, 705, 10.1182/blood.V72.2.705.705
Hoelzer, 1988, Phase I/II study with GM-CSF in patients with myelodysplastic syndromes, Behring Inst Mitt, 83, 134
Antin, 1990, Variable effect of recombinant human granulocyte-macrophage colony-stimulating factor on bone marrow fibrosis in patients with myelodysplasia, Exp Hematol, 18, 266
Thompson, 1989, Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodyslastic syndrome: Toxicity, pharmacokinetics, and hematological effects, J Clin Oncol, 7, 629, 10.1200/JCO.1989.7.5.629
Ganser, 1989, Recombinant human grnaulocytemacrophage colony-stimulating factor in patients with myelodysplastic syndromes: A phase I/II trial, Blood, 73, 31, 10.1182/blood.V73.1.31.31
Nissen, 1988, Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropenia, Blood, 72, 2045, 10.1182/blood.V72.6.2045.2045
Vadhan-Raj, 1988, Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor, N Engl J Med, 319, 1628, 10.1056/NEJM198812223192503
Champlin, 1989, Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage colony-stimulating factor, Blood, 73, 694, 10.1182/blood.V73.3.694.694
Rifkin, 1988, A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion, Behring Inst Mitt, 83, 125
Guinan, 1990, A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia, Blood, 76, 1077, 10.1182/blood.V76.6.1077.1077
Ganser, 1989, The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia, Ann Intern Med, 111, 887, 10.7326/0003-4819-111-11-887
Vadhan-Raj, 1990, Stimulation of myelopoiesis in a patient with congenital neutropenia: Biology and nature of response to recombinant human granulocyte-macrophage colony-stimulating factor, Blood, 75, 858, 10.1182/blood.V75.4.858.858
Lothrop, 1988, Correction of canine cyclic hematopoiesis with recombinant human granulocyte colonystimulating factor, Blood, 72, 1324, 10.1182/blood.V72.4.1324.1324
Freund, 1990, Differential effect of GM-CSF and G-CSF in cyclic neutropenia, Lancet, 10.1016/0140-6736(90)91849-6
Hammond, 1990, A comparison of treatment of canine cyclic hematopoiesis with recombinant human granulocytemacrophage colony-stimulating factor (GM-CSF), G-CSF interleukin-3, and canine G-CSF, Blood, 76, 523, 10.1182/blood.V76.3.523.523
Buchner, 1991, Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse, Blood, 78, 1190, 10.1182/blood.V78.5.1190.1190
Estey, 1990, Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor, Blood, 75, 1766, 10.1182/blood.V75.9.1766.1766
Cannistra, 1991, Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia, Leukemia, 5, 230
Bettelheim, 1991, Recombinant human granulocyte-macrophage, colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia, Blood, 77, 700, 10.1182/blood.V77.4.700.700
Lieschke, 1990, Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration, Cancer Res, 50, 606
Lieschke, 1989, Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy, Ann Intern Med, 110, 357, 10.7326/0003-4819-110-5-357
Cebon, 1990, The pharmacokinetic correlates of GM-CSF efficacy and toxicity, Proc Am Soc Clin Oncol, 9, 182
Gribben, 1990, Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF, Lancet, 335, 434, 10.1016/0140-6736(90)90665-R
Burgess, 1980, Granulocyte-macrophage, megakaryocyte, eosinophil, and erythroid colony-stimulating factors produced by mouse spleen cells, Biochem J, 185, 301, 10.1042/bj1850301
Clark-Lewis, 1984, Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of hemopoietic cells, J Biol Chem, 25, 7488, 10.1016/S0021-9258(17)42817-1
Yokota, 1981, Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth factor activity in monkey cells, Proc Natl Acad Sci USA, 81, 1070, 10.1073/pnas.81.4.1070
Yang, 1987, The human genes for GM-CSF and IL-3 are closely linked in tandem on chromosome 5, Blood, 71, 958, 10.1182/blood.V71.4.958.958
Niemeyer, 1989, Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines, Blood, 73, 945, 10.1182/blood.V73.4.945.945
Otsuka, 1991, Differential effects of microenvironmentally presented interleukin-3 versus soluble growth factor on primitive human hematopoietic cells, J Clin Invest, 88, 417, 10.1172/JCI115320
Lopez, 1987, Stimulation of proliferation, differentiation, and function of human cells by primate interleukin-3, Proc Natl Acad Sci USA, 84, 2761, 10.1073/pnas.84.9.2756
Leary, 1987, Recombinant gibbon interleukin-3 supports formation of human multilineage colonies and blast cell colonies in culture: Comparison with recombinant human granulocyte-macrophage colony-stimulating factor, Blood, 70, 1343, 10.1182/blood.V70.5.1343.1343
Lopez, 1988, Recombinant human interleukin-3 stimulation of hematopoiesis in humans: Loss of responsiveness with differentiation in the neutrophilic myeloid series, Blood, 72, 1797, 10.1182/blood.V72.5.1797.1797
Emerson, 1988, Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin-3 have overlapping but distinct hemopoietic activities, J Clin Invest, 82, 1282, 10.1172/JCI113727
Bruno, 1988, Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation, Exp Hematol, 16, 371
Teramura, 1989, Effect of recombinant hemopoietic growth factors on human megakaryocyte colony formation in serum-free cultures, Exp Hematol, 17, 1011
Broxmeyer, 1987, Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor-1, recombinant murine interleukin-3, and recombinant murine granulocyte/macrophage colony-stimulating factor, Proc Natl Acad Sci USA, 84, 3871, 10.1073/pnas.84.11.3871
Donahue, 1988, Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates, Science, 241, 1820, 10.1126/science.3051378
Mayer, 1989, The in vivo effect of recombinant human man interleukin-3: Demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates, Blood, 74, 613, 10.1182/blood.V74.2.613.613
Ulich, 1990, Acute and subacute hematologic effects of multi-colony stimulating factor in combination with granulocyte colonystimulating factor in vivo, Blood, 75, 48, 10.1182/blood.V75.1.48.48
Uckun, 1989, Leukemic B cell precursors express functional receptors for interleukin-3, Blood, 73, 533, 10.1182/blood.V73.2.533.533
Brantschen, 1989, Factors influencing proliferation and histamine content of cultured human bone marrow cells, Immunobiology, 179, 271, 10.1016/S0171-2985(89)80022-1
Valent, 1989, Interleukin-3 is a differentiation factor for human basophils, Blood, 73, 1763, 10.1182/blood.V73.7.1763.1763
Ganser, 1990, Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes, Blood, 76, 455, 10.1182/blood.V76.3.455.455
Kurzrock, 1991, Phase I study of recombinant human interleukin-3 in patients with bone marrow failure, J Clin Oncol, 9, 1241, 10.1200/JCO.1991.9.7.1241
Ganser, 1990, Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure, Blood, 76, 666, 10.1182/blood.V76.4.666.666
Lindemann, 1991, Biologic effects of recombinant human interleukin-3 in vivo, J Clin Oncol, 9, 2120, 10.1200/JCO.1991.9.12.2120
Demetri, 1991, Clinical effects of interleukin-3 (IL-3) in patients with advanced sarcomas: A phase I/II trial, Blood, 78, 5
Gillio, 1991, Human recombinant interleukin-3 treatment in patients with myelodysplastic syndrome and aplastic anemia, Blood, 78, 95
Hoelzer, 1991, Interleukin-3 alone and in combination with GM-CSF in the treatment of patients with neoplastic disease, Semin Hematol, 28, 17
Brugger, 1991, Combined sequential administration of Il-3 + GM-CSF after polychemotherapy with etoposide, ifosfamide, and cisplatin, Blood, 78, 162
Tepler, 1991, Effect of recombinant human interleukin-3 (IL-3) on hematologic recovery from chemotherapy-induced myelosuppression: A phase I/II study, Blood, 78, 162
Gianni, 1990, Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma, J Clin Oncol, 8, 768, 10.1200/JCO.1990.8.5.768
Fibbe, 1991, Recombinant human interleukin-3 after autologous bone marrow transplantation for malignant lymphoma: A phase I/II multicenter study, Blood, 78, 163
Paul, 1991, Interleukin-4: A prototype immunoregulatory lymphokine, Blood, 77, 1859, 10.1182/blood.V77.9.1859.1859
Howard, 1982, Identification on a T-cell derived B-cell grwoth factor distinct from interleukin-2, J Exp Med, 155, 914, 10.1084/jem.155.3.914
Lee, 1986, Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell and mast-cell-stimulating activities, Proc Natl Acad Sci USA, 83, 2061, 10.1073/pnas.83.7.2061
Noma, 1986, Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter, Nature, 319, 640, 10.1038/319640a0
Le, 1988, Isolation and characterization of multiple variants of recombinant human interleukin-4 expressed in mammalian cells, J Biol Chem, 263, 10817, 10.1016/S0021-9258(18)38043-8
Peschel, 1987, Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells, Blood, 70, 254, 10.1182/blood.V70.1.254.254
Rennick, 1987, Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells, Proc Natl Acad Sci USA, 84, 6889, 10.1073/pnas.84.19.6889
Vellenga, 1990, Divergent effects of interleukin-4 (IL-4) on the granulocyte colony-stimulating factor and IL-3-supported myeloid colony formation from normal and leukemic bone marrow cells, Blood, 75, 633, 10.1182/blood.V75.3.633.633
Mosmann, 1986, T cell and mast cell lines respond to B-cell stimulatory factor-1, Proc Natl Acad Sci USA, 83, 5654, 10.1073/pnas.83.15.5654
Jansen, 1989, Inhibition of human macrophage colony formation by interleukin 4, J Exp Med, 170, 577, 10.1084/jem.170.2.577
Peschel, 1989, Interleukin-4 induces a substance in bone marrow stromal cells which reversibly inhibits factor-dependent and factor-independent cell proliferation, Blood, 73, 1130, 10.1182/blood.V73.5.1130.1130
Tepper, 1989, Murine interleukin-4 displays potent anti-tumor activity in vivo, Cell, 57, 503, 10.1016/0092-8674(89)90925-2
Golumbek, 1991, Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4, Science, 254, 713, 10.1126/science.1948050
Crawford, 1987, BSF-1: A new macrophage activation factor: B cell stimulatory factor-1 (interleukin-4) activates macrophages for increased tumoricidal activity and expression of Ia antigens, J Immunol, 139, 135, 10.4049/jimmunol.139.1.135
Herrmann, 1991, Interleukin-4 inhibits growth of multiple myeloma by suppressing interleukin-6 expression, Blood, 78, 2070, 10.1182/blood.V78.8.2070.2070
Mosely, 1989, The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane forms, Cell, 59, 335, 10.1016/0092-8674(89)90295-X
Fernandez-Botran, 1990, A soluble, high-affinity interleukin-4-binding protein is present in the biological fluids of mice, Proc Natl Acad Sci USA, 87, 4204, 10.1073/pnas.87.11.4202
Dinarello, 1991, Interleukin-1 and interleukin-1 antagonism, Blood, 77, 1627, 10.1182/blood.V77.8.1627.1627
Dinarello, 1991, Interleukin-1 and interleukin-1 antagonism, Blood, 77, 1627, 10.1182/blood.V77.8.1627.1627
Auron, 1984, Nucleotide sequence of human monocyte interleukin-1 precursr cDNA, Proc Natl Acad Sci USA, 81, 7907, 10.1073/pnas.81.24.7907
Lomedico, 1984, Cloning and expression of murine interleukin-1 cDNA in Escherichia coli, Nature, 312, 458, 10.1038/312458a0
Jubinsky, 1985, Purification of hemopoietin-1: A multilineage hematopoietic growth factor, Proc Natl Acad Sci USA, 82, 2764, 10.1073/pnas.82.9.2764
Mochizuki, 1987, Interleukin-1 regulates he- matopoietic activity, a role previously ascribed to hemopoietin 1, Proc Natl Acad Sci USA, 84, 5267, 10.1073/pnas.84.15.5267
Moore, 1987, Synergy of interleukin-1 and granulocyte colony-stimulating factor: In vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice, Proc Natl Acad Sci USA, 84, 7134, 10.1073/pnas.84.20.7134
Moore, 1990, Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil, J Natl Cancer Inst, 82, 1031, 10.1093/jnci/82.12.1031
Bagby, 1986, Interleukin-1 stimulates granulocyte-macrophage colony-stimulating activity release by vascular endothelial cells, J Clin Invest, 78, 1316, 10.1172/JCI112717
Zucali, 1986, Interleukin-1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2, J Clin Invest, 77, 1857, 10.1172/JCI112512
Zsebo, 1988, Vascular endothelial cells and granulopoiesis: Interleukin-1 stimulates release of G-CSF and GM-CSF, Blood, 71, 99, 10.1182/blood.V71.1.99.99
Schooley, 1987, Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anemias, Br J Haematol, 67, 11, 10.1111/j.1365-2141.1987.tb02289.x
Johnson, 1989, In vivo hematopoietic effects of recombinant interleukin-1a in mice: Stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin, Blood, 73, 678, 10.1182/blood.V73.3.678.678
Neta, 1988, Interdependence of the radioprotective effects of human recombinant interleukin-1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, J Immunol, 140, 108, 10.4049/jimmunol.140.1.108
Stork, 1989, Interleukin-1 accelerates murine granulocyte recovery following treatment with cyclophosphamide, Blood, 73, 938, 10.1182/blood.V73.4.938.938
Fibbe, 1989, A single dose of human recombinant interleukin-1 accelerates the recovery of neutrophils in mice with cyclophosphamide-induced neutropenia, Exp Hematol, 17, 805
Starnes, 1991, Biological effects and possible clinical applications of interleukin-1, Semin Hematol, 28, 34
Crown, 1990, Phase I–II trial of recombinant human interleukin-1β (IL-1) in patients with metastatic colorectal cancer receiving myelosuppressive doses of 5-fluorouracil, Proc Am Soc Clin Oncol, 9, 183
Smith, 1990, Interleukin-1-alpha (IL-1a): Results of a phase I toxicity and immunomodulatory trial, Proc Am Soc Clin Oncol, 9, 186
Vredenburgh, 1991, Phase I trial of interleukin-1β (IL-1β) following high-dose chemotherapy and autologous bone marrow transplantation (ABMT), Blood, 78
Tewari, 1990, Preliminary report: Effects of interleukin-1 on platelet counts, Lancet, 336, 712, 10.1016/0140-6736(90)92206-W
Kishimoto, 1973, Regulation of antibody response in vitro. VII. Enhancing soluble factors for IgG and IgE antibody response, J Immunol, 111, 1194, 10.4049/jimmunol.111.4.1194
Hirano, 1986, Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin, Nature, 324, 73, 10.1038/324073a0
Gauldie, 1987, Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells, Proc Natl Acad Sci USA, 84, 7251, 10.1073/pnas.84.20.7251
Jablons, 1989, IL-6/IFN-β2 as a circulating hormone: Induction by cytokine administration in humans, J Immunol, 142, 1542, 10.4049/jimmunol.142.5.1542
Hack, 1989, Increased plasma levels of interleukin-6 in sepsis, Blood, 74, 1704, 10.1182/blood.V74.5.1704.1704
Tovey, 1989, Expression of IL-6 in normal individuals and in patients with autoimmune disease, Ann NY Acad Sci, 557, 363, 10.1111/j.1749-6632.1989.tb24029.x
Shabo, 1988, Target cell specificity of hematopoietic regulatory proteins for different clones of myeloid leukemic cells: Two regulators secreted by Krebs carcinoma cells, Int J Cancer, 41, 622, 10.1002/ijc.2910410424
Sachs, 1987, The molecular control of blood cell development, Science, 238, 1374, 10.1126/science.3317831
Shabo, 1988, The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6, Blood, 72, 2070, 10.1182/blood.V72.6.2070.2070
Van Damme, 1987, Identification of the human 26-kD protein, interferon-β2 (IFN-β2), as a B-cell hybridoma/plasmacytoma growth factor induced by interleukin-1 and tumor necrosis factor, J Exp Med, 165, 914, 10.1084/jem.165.3.914
Kawano, 1988, Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas, Nature, 332, 83, 10.1038/332083a0
Leger-Ravet, 1991, Interleukin-6 gene expression in Castlemen's disease, Blood, 78, 2923, 10.1182/blood.V78.11.2923.2923
Mule, 1991, Antitumor activity of recombinant interleukin 6 in mice, J Exp Med, 171, 629, 10.1084/jem.171.3.629
Suda, 1988, Effect of interleukin-6 (IL-6) on the differentiation and proliferation of murine and human hematopoietic progenitors, Exp Hematol, 16, 891
Caracciolo, 1989, Human interleukin-6 supports granulocytic differentiation of hematopoietic cells and acts synergistically with GM-CSF, Blood, 73, 666, 10.1182/blood.V73.3.666.666
Wong, 1988, Stimulation of murine hemopoietic colony formation by human IL-6, J Immunol, 140, 3040, 10.4049/jimmunol.140.9.3040
Ikebuchi, 1987, Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors, Proc Natl Acad Sci USA, 84, 9035, 10.1073/pnas.84.24.9035
Leary, 1988, Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: Comparison with interleukin-1-alpha, Blood, 71, 1759, 10.1182/blood.V71.6.1759.1759
Koike, 1988, Synergism of BSF-2/interleukin-6 and interleukin-3 on the development of multipotential hemopoietic progenitors in serum-free culture, J Exp Med, 168, 879, 10.1084/jem.168.3.879
Ishibashi, 1989, Interleukin-6 is a potent thrombopoietic factor in vivo in mice, Blood, 74, 1241, 10.1182/blood.V74.4.1241.1241
Asano, 1990, In vivo effects of recombinant human interleukin-6 in primates: Stimulated production of platelts, Blood, 75, 1602, 10.1182/blood.V75.8.1602.1602
Hill, 1991, Stimulation of megakaryocytopoiesis in mice by human recombinant interleukin-6, Blood, 77, 42, 10.1182/blood.V77.1.42.42
Carrington, 1991, Multiple in vivo effects of interleukin-3 and interleukin-6 on murine megakaryocytopoiesis, Blood, 77, 34, 10.1182/blood.V77.1.34.34
Mayer, 1991, Recombinant human interleukin-6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates, Exp Hermatol, 19, 688
Williams, 1991, Is thrombopoietin interleukin-6?, Exp Hematol, 19, 714
Takatsuki, 1990, Interleukin-6 perfusion stimulates reconstitution of the immune and hematopoietic systems after 5-fluorouracil treatment, Cancer Res, 50, 2885
Patchen, 1991, Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression, Blood, 77, 472, 10.1182/blood.V77.3.472.472
McCulloch, 1965, The cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype Sl/Sld, Blood, 26, 399, 10.1182/blood.V26.4.399.399
McCulloch, 1964, Spleen-colony formation in anemic mice of genotype W/Wv, Science, 144, 844, 10.1126/science.144.3620.844
Nocka, 1990, Molecular bases of dominant negative and loss of function mutations at the murine c-kit/ white spotting locus: W(37), W(v), W(41), and W, EMBO J, 9
Reith, 1990, W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor, Genes Dev, 4, 390, 10.1101/gad.4.3.390
Zsebo, 1990, Identification, purification, and biological characterization of hematopoietic stem cell factor from Buffalo rat liver-conditioned medium, Cell, 63, 195, 10.1016/0092-8674(90)90300-4
Zsebo, 1990, Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor, Cell, 63, 213, 10.1016/0092-8674(90)90302-U
Williams, 1990, Identification of a ligand for the c-kit proto-oncogene, Cell, 63, 167, 10.1016/0092-8674(90)90297-R
Huang, 1990, The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus, Cell, 63, 225, 10.1016/0092-8674(90)90303-V
Martin, 1990, Primary structure and functional expression of rat and human stem cell factor DNAs, Cell, 63, 203, 10.1016/0092-8674(90)90301-T
Anderson, 1990, Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms, Cell, 63, 235, 10.1016/0092-8674(90)90304-W
Witte, 1990, Steel locus defines a new multipotent growth factor, Cell, 63, 5, 10.1016/0092-8674(90)90280-R
Catlett, 1991, c-kit expression by CD34+ bone marrow progenitors and inhibition of response to recombinant human interleukin-3 following exposure to c-kit antisense oligonucleotides, Blood, 78, 3186, 10.1182/blood.V78.12.3186.3186
Long, 1991, Adhesion of human hematopoietic progenitor cells (HPCs) to cytokines and extracellular matrix (ECM) proteins, Blood, 78, 157
McNiece, 1991, Recombinant human stem cell factor synergizes with Gm-CSF, G-CSF, IL-3, and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages, Exp Hematol, 19, 226
Bernstein, 1991, Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin-cells, and the generation of colony-forming progeny from CD34+lin-cells cultured with interleukin-3, granulocyte colony-stimulating factor, Blood, 77, 2316, 10.1182/blood.V77.11.2316.2316
Briddell, 1991, Effect of c-kit ligand on in vitro human megakaryocytopoiesis, Blood, 78, 2854, 10.1182/blood.V78.11.2854.2854
Abkowitz, 1991, Diamond-Blackfan anemia: In vitro response to erythroid progenitors to the ligand for c-kit, Blood, 78, 2198, 10.1182/blood.V78.9.2198.2198
Bagnara, 1991, In vitro growth and regulation of bone marrow enriched CD34+hematopoietic progenitors in Diamond-Blackfan anemia, Blood, 78, 2203, 10.1182/blood.V78.9.2203.2203
Miles, 1991, Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias, Blood, 78, 3200, 10.1182/blood.V78.12.3200.3200
Andrews, 1991, Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates, Blood, 78, 1975, 10.1182/blood.V78.8.1975.1975
Ulich, 1991, Stem cell factor in combination with granulocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF synergistically increases granulopoiesis in vivo, Blood, 78, 1954, 10.1182/blood.V78.8.1954.1954
Mushashi, 1991, Direct and synergistic effects of interleukin-11 on murine hemopoiesis in culture, Proc Natl Acad Sci USA, 88, 765, 10.1073/pnas.88.3.765
Paul, 1991, IL-11 expression in donor bone marrow cells improves hematological reconstitution in lethally irradiated recipient mice, Blood, 78, 260
Goldman, 1991, Recombinant human interleukin-11 (rhIL-11) stimulated megakaryocyte maturation and increase in peripheral platelet number in vivo, Blood, 78, 132
Neben, 1991, Interleukin-11 synergizes markedly with other hematopoietic growth factors in vitro to expand murine committed progenitor cells without increased loss of primitive stem cells, Blood, 78, 157
Bruno, 1991, Effects of recombinant interleukin-11 on human megakaryocyte progenitor cells, Exp Hematol, 19, 378
Du, 1991, Effects of recombinant interleukin-11 on, Blood, 78, 403
Yang, 1989, Expression cloning of a cDNA encoding a novel hematopoietic growth factor: Human homologue of murine T-cell growth factor P40, Blood, 74, 1880, 10.1182/blood.V74.6.1880.1880
Donahue, 1990, Human P40 T-cell growth factor (interleukin-9) supports erythroid colony formation, Blood, 75, 2271, 10.1182/blood.V75.12.2271.2271
Van Snick, 1989, Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40), J Exp Med, 169, 363, 10.1084/jem.169.1.363
Williams, 1988, Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells, Natue, 336, 684, 10.1038/336684a0
Smith, 1988, Inhibition of pluripotential stem cell differentiation by purified polypeptides, Nature, 336, 688, 10.1038/336688a0
Gearing, 1987, Molecular cloning and expression of cDNA encoding a murine myeloid leukemia inhibitory factor (LIF), EMBO J, 6, 3395, 10.1002/j.1460-2075.1987.tb02742.x
Gough, 1988, Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor, Proc Natl Acad Sci USA, 85, 2623, 10.1073/pnas.85.8.2623
Goddad, 1988, Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells, Blood, 71, 1618, 10.1182/blood.V71.6.1618.1618
Moreau, 1988, Leukemia inhibition factor is identical to the myeloid growth factor human interleukin for DA cells, Nature, 336, 690, 10.1038/336690a0
Leary, 1990, Leukemia-inhibitory factor, differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells, Blood, 75, 1960, 10.1182/blood.V75.10.1960.1960
Verfaillie, 1991, Leukemia inhibitory factor/human interleukin for DA cells: A growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors, Blood, 77, 263, 10.1182/blood.V77.2.263.263
Williams, 1990, Enhanced biological activity of a human GM-CSF/IL-3 fusion protein, Exp Hematol, 18, 615
Baggliolini, 1989, Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils, J Clin Invest, 84, 1045, 10.1172/JCI114265
Anisowicz, 1987, Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells, Proc Natl Acad Sci USA, 84, 7188, 10.1073/pnas.84.20.7188
Broxmeyer, 1991, Comparative analysis of the suppressive effects of human proinflammatory sumergene “intercrine” family cytokines on proliferation of human myeloid progenitor cells, Blood, 78, 1028
Kishi, 1989, The suppressive effects of type beta transforming growth factor (TGF-beta) on primitive murine hemopoietic progenitors are abrogated by interleukin-6 and granulocyte colony-stumulating factor, Leukemia, 3, 687
Schneider, 1991, TGFβ, but not macrophage inflammatory protein-1 alpha (MIP1a) abrogates IL-1 and c-kit ligand (KL) induced proliferation of murine high proliferative potential (HPP) colonies, Blood, 78, 1027
Aglietta, 1989, Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis, Exp Hematol, 17, 296
Aglietta, 1989, Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor, J Clin Invest, 83, 551, 10.1172/JCI113917
Seckinger, 1987, A urine inhibitor of interleukin-1 activity that blocks ligand binding, J Immunol, 1546, 10.4049/jimmunol.139.5.1546
Eisenberg, 1990, Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist, Nature, 343, 341, 10.1038/343341a0
Engelmann, 1989, A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity, J Biol Chem, 264, 11974, 10.1016/S0021-9258(18)80162-4
Novick, 1989, Soluble cytokine receptors are present present in normal human urine, J Exp Med, 170, 1409, 10.1084/jem.170.4.1409
Fanslow, 1990, Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor, Science, 248, 739, 10.1126/science.2139736
Walker, 1985, Hierarchical down-modulation of hemopoietic growth factor receptors, Cell, 43, 269, 10.1016/0092-8674(85)90032-7
Nicola, 1986, Identification of distinct receptors for two hemopoietic growth factors (granulocyte colony-stimulating factor and multipotential colony-stimulating factor) by chemical cross-linking, J Biol Chem, 261, 12384, 10.1016/S0021-9258(18)67251-5
Nicola, 1989, Hemopoietic cell growth factors and their receptors, Annu Rev Biochem, 58, 45, 10.1146/annurev.bi.58.070189.000401
Bazan, 1989, A novel family of growth factor receptor: A common binding domain in the growth hormone, prolactin, erythropoietin, and IL-6 receptor, and the p75 IL-2 receptor beta chain, Biochem Biophys Res Commun, 164, 788, 10.1016/0006-291X(89)91528-3
Cosman, 1990, A new cytokine receptor superfamily, Trends Biochem Sci, 15, 265, 10.1016/0968-0004(90)90051-C
Nicola, 1991, Subunit promiscuity among hemopoetic growth factor receptors, Cell, 67, 1, 10.1016/0092-8674(91)90564-F
Kitamura, 1991, Expression cloning of the human IL-3 receptor reveals a shared β subunit for the human IL-3 and GM-CSF receptors, Cell, 66, 1165, 10.1016/0092-8674(91)90039-2
Tavernier, 1991, A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a β chain shared with the receptor for GM-CSF, Cell, 66, 1175, 10.1016/0092-8674(91)90040-6
Cannistra, 1988, Human granulocyte-monocyte colony-stimulating factor and interleukin-3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism, Blood, 71, 672, 10.1182/blood.V71.3.672.672
Rothenberg, 1988, Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin-3, J Clin Invest, 81, 1986, 10.1172/JCI113547
Kurimoto, 1989, Inteleukin-3-dependent mediator release in basophils triggered by C5a, J Exp Med, 170, 467, 10.1084/jem.170.2.467
Demetri, 1990, GM-CSF and G-CSF have different effects on expression of the neutrophil adhesion receptors LAM-1 and CD11b, Blood, 76, 178|a
Peters, 1988, Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans, Blood, 72, 1310, 10.1182/blood.V72.4.1310.1310
Socinski, 1988, Granulocyte-macrophage colonystimulating factor expands the circulating haemopoietic progenitor cell compartment in man, Lancet, 1194, 10.1016/S0140-6736(88)92012-0
Gianni, 1989, Rapid and complete hematopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells: A changing role for high dose chemoradiotherapy, Hematol Oncol, 7, 139, 10.1002/hon.2900070205
Kessinger, 1991, The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies, Blood, 77, 211, 10.1182/blood.V77.2.211.211
Elias, 1992, Mobilization of peripheral blood progenitor cells by chemotherapy and GM-CSF for hematologic support after high dose intensification for breast cancer, Blood, 10.1182/blood.V79.11.3036.3036
Mauch, 1991, Mobilization of different blood stem cell subpopulations in the mouse with cyclophosphamide (CY) and/or G-CSF, Blood, 78, 987
Monroy, 1991, Development of factor administration schedules to increase peripheral blood stem cells (PBSC) in normal primates: A comparison using IL-1, GM-CSF, and IL-3, Blood, 78, 163